Product
ION251
1 clinical trial
1 indication
Indication
Multiple MyelomaClinical trial
A Phase 1 Study of ION251 Administered by Intravenous Infusion to Patients With Relapsed/Refractory Multiple MyelomaStatus: Active (not recruiting), Estimated PCD: 2024-01-01